India Glycols Intrinsic Value
INDIAGLYCO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1051.00 | ₹840.80 - ₹1261.20 | +10.2% | EPS: ₹42.04, Sector P/E: 25x |
| Book Value Method | asset | ₹1819.35 | ₹1637.41 - ₹2001.29 | +90.8% | Book Value/Share: ₹727.74, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹1907.00 | ₹1716.30 - ₹2097.70 | +100.0% | Revenue/Share: ₹1427.10, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹1907.00 | ₹1716.30 - ₹2097.70 | +100.0% | EBITDA: ₹684.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹1586.18 | ₹1268.94 - ₹1903.42 | +66.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹286.05 | ₹257.44 - ₹314.66 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹779.42 | ₹701.48 - ₹857.36 | -18.3% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹1006.45 | ₹905.81 - ₹1107.10 | +5.6% | ROE: 11.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹829.68 | ₹746.71 - ₹912.65 | -13.0% | EPS: ₹42.04, BVPS: ₹727.74 |
Want to compare with current market value? Check INDIAGLYCO share price latest .
Valuation Comparison Chart
INDIAGLYCO Intrinsic Value Analysis
What is the intrinsic value of INDIAGLYCO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of India Glycols (INDIAGLYCO) is ₹1051.00 (median value). With the current market price of ₹953.50, this represents a +10.2% variance from our estimated fair value.
The valuation range spans from ₹286.05 to ₹1907.00, indicating ₹286.05 - ₹1907.00.
Is INDIAGLYCO undervalued or overvalued?
Based on our multi-method analysis, India Glycols (INDIAGLYCO) appears to be trading below median value by approximately 10.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.14 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.74 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 11.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.72x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for India Glycols
Additional stock information and data for INDIAGLYCO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹362 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹439 Cr | ₹187 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹326 Cr | ₹161 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹116 Cr | ₹116 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹137 Cr | ₹63 Cr | Positive Free Cash Flow | 7/10 |